Private Equity
Anonyome Labs, a consumer privacy startup, has secured $20.4 in million Series B funding. The investors included John Mumford, founder of Mumford; Todd Davis, founder of LifeLock; Greg Clark, CEO of Symantec; and Hanna Ventures. In conjunction with the funding, Anonyome has appointed Davis to its board.
1 min read · 28 August 2017
South San Francisco-based Freenome, a health tech company, has secured $7 million in funding. Section 32 led the round.
3 min read · 28 August 2017
Joy Capital is seeking to raise $300 million for its second fund, according to an SEC filing. Previously, the Chinese venture firm raised $200 million for its debut fund, as previously reported by PE HUB.
1 min read · 28 August 2017
Insurance tech startup Sherpa has raised $2.3 million in funding, according to a blog post on its site. The investors were not named.
1 min read · 28 August 2017
Bamboo Ventures has closed $1 million for Bamboo Commerce, its new omnichannel platform. Based in Ann Arbor, Michigan, Bamboo Commerce is a web-based inventory, order management, CRM and fulfillment platform for online retailers, manufacturers and companies.
1 min read · 28 August 2017
Chicago and New York-based Outcome Health, a provider of health intelligence that improves patient outcomes, has named Nandini Ramani as chief engineering officer. Previously, Ramani worked at Twitter. Outcome Health's backers include Goldman Sachs Investment Partners, CapitalG, Leerink Transformation Partners, Pritzker Group Venture Capital and Balyansy Asset Management.
2 min read · 28 August 2017
CF PharmTech Inc, a maker of inhalation products, has raised $65 million in Series D financing. Future Industry Investment Fund was the lead investor.
1 min read · 28 August 2017
Hubble, a direct-to-consumer contact lens brand, has raised $10 million in funding. The investors included FirstMark Capital, Greycroft Partners, Founders Fund, Wildcat Capital Management and Two River.
1 min read · 28 August 2017
Santa Clarita, California-based SetPoint Medical, a developer of bioelectronic therapy for chronic inflammatory diseases, has raised $30 million in Series D funding. The investors included New Enterprise Associates, Morgenthaler, Medtronic, Boston Scientific, Topspin and Action Potential Venture Capital.
2 min read · 28 August 2017
Berlin-based EBS Technologies, a medical device company that treats visual field loss, has appointed Karl Schweitzer as CEO. Previously, he worked at Medtronic. EBS Technologies' backers include Earlybird and Norgine Ventures.
3 min read · 28 August 2017
